1,285,193 Shares in Corteva, Inc. $CTVA Purchased by Canoe Financial LP

Canoe Financial LP bought a new stake in Corteva, Inc. (NYSE:CTVA) in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 1,285,193 shares of the company’s stock, valued at approximately $107,584,000. Canoe Financial LP owned approximately 0.19% of Corteva as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of CTVA. Brighton Jones LLC increased its stake in shares of Corteva by 307.2% during the fourth quarter. Brighton Jones LLC now owns 15,588 shares of the company’s stock valued at $888,000 after acquiring an additional 11,760 shares during the period. Woodline Partners LP boosted its stake in Corteva by 40.3% during the first quarter. Woodline Partners LP now owns 57,919 shares of the company’s stock valued at $3,645,000 after buying an additional 16,644 shares in the last quarter. EverSource Wealth Advisors LLC boosted its stake in Corteva by 62.1% during the second quarter. EverSource Wealth Advisors LLC now owns 2,559 shares of the company’s stock valued at $191,000 after buying an additional 980 shares in the last quarter. Cresset Asset Management LLC grew its holdings in Corteva by 2.6% during the second quarter. Cresset Asset Management LLC now owns 7,063 shares of the company’s stock worth $526,000 after acquiring an additional 181 shares during the period. Finally, Jump Financial LLC acquired a new position in Corteva during the second quarter worth about $1,464,000. Institutional investors and hedge funds own 81.54% of the company’s stock.

Corteva Trading Down 0.0%

NYSE:CTVA opened at $82.60 on Monday. The company has a quick ratio of 1.03, a current ratio of 1.47 and a debt-to-equity ratio of 0.07. Corteva, Inc. has a 1-year low of $60.53 and a 1-year high of $85.63. The firm has a market capitalization of $55.24 billion, a price-to-earnings ratio of 48.59, a price-to-earnings-growth ratio of 2.53 and a beta of 0.57. The stock has a fifty day simple moving average of $79.38 and a 200 day simple moving average of $76.28.

Corteva (NYSE:CTVA) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, beating analysts’ consensus estimates of $1.18 by $0.32. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The company had revenue of $4.91 billion during the quarter, compared to analyst estimates of $4.64 billion. During the same period in the prior year, the firm earned $1.13 earnings per share. The business’s quarterly revenue was up 11.0% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Sell-side analysts forecast that Corteva, Inc. will post 3.72 earnings per share for the current year.

Corteva Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, June 15th. Investors of record on Monday, June 1st were paid a $0.18 dividend. The ex-dividend date of this dividend was Monday, June 1st. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. Corteva’s dividend payout ratio (DPR) is currently 42.35%.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on CTVA. Royal Bank Of Canada upped their price target on shares of Corteva from $95.00 to $97.00 and gave the company an “outperform” rating in a report on Thursday, May 7th. Jefferies Financial Group lifted their price objective on shares of Corteva from $95.00 to $97.00 in a research note on Thursday, May 7th. Weiss Ratings upgraded shares of Corteva from a “hold (c)” rating to a “hold (c+)” rating in a report on Thursday, May 7th. Oppenheimer increased their target price on shares of Corteva from $86.00 to $89.00 and gave the company an “outperform” rating in a research note on Wednesday, April 22nd. Finally, BNP Paribas Exane raised their target price on shares of Corteva from $74.00 to $77.00 in a report on Wednesday, May 6th. Fourteen analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. According to data from MarketBeat.com, Corteva currently has an average rating of “Moderate Buy” and a consensus target price of $88.81.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.